Comments: NJ A277 | 2020-2021 | Regular Session

Bill Title: Requires public members of Drug Utilization Review Board to disclose financial interests and benefits received from and investment interests held in pharmaceutical distributors, pharmaceutical manufacturers, or pharmacy benefits managers.

Sponsorship: Partisan Bill (Democrat 6)

Status: (Passed) 2021-11-08 - Approved P.L.2021, c.285. [A277 Detail]

Text: Latest bill text (Chaptered) [HTML]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2020 New Jersey A277 at this time.

feedback